B cells as a cellular adjuvant: Induction or control of T-cell immunity - Or both?

Expert Review of Vaccines

Volumn 6, Issue 5, 2007, Pages 667-671

  Von Bergwelt Baildon, Michael ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Antigen presenting cell; B cell; CD40 activated B cell; Cellular adjuvant

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2;

ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; FLUORESCENCE ACTIVATED CELL SORTING; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOHISTOCHEMISTRY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

EID: 35348967831     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.6.5.667     Document Type: Article

References (26)

1. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137(5), 1142-1162 (1973).
2. Banchereau J, Schuler-Thurner B, Palucka AK, Schuler G. Dendritic cells as vectors for therapy. Cell 106, 271-274 (2001).
3. Rutella S, Danese S, Leone G. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 108, 1435-1440 (2006).
4. von Bergwelt-Baildon MS, Saric T, Chemnitz J et al. CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition. Blood 108, 228-237 (2006).
5. Gunzer MJS, Varga G, Grabbe S. Dendritic cells and tumor immunity. Semin. Immunol. 13, 291-302 (2001).
6. Barratt-Boyes SM, Zimmer MI, Harshyne LA et al. Maturation and trafficking of monocyte-derived dendritic cells in monkeys: implications for dendritic cell-based vaccines. J. Immunol. 164, 2487-2495 (2000).
7. Maus MV, Thomas AK, Leonard DG et al. Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB. Nat. Biotechnol. 20, 143-148 (2002).
8. Latouche JB, Sadelain M. Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells. Nat. Biotechnol. 18, 405-409 (2000).
9. Schultze JL, Michalak S, Seamon MJ et al. CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. J. Clin. Invest. 100, 2757-2765 (1997).
10. von Bergwelt-Baildon MS, Popov A, Klein-Gonzalez N et al. CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants. Blood 107, 2786-2789 (2006).
11. Kondo E, Kiem HP, Obata Y et al. Efficient generation of antigen-specific cytotoxic T cells using retrovirally transduced CD40-activated B cells. J. Immunol. 169, 2164-2171 (2002).
12. Fuchs E. B cells turn off virgin but not memory T cells. Science 258, 1156-1159 (1992).
13. Mizoguchi A, Bhan AK. A case for regulatory B cells. J. Immunol. 175, 705-710 (2006).
14. Fillatreau S, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3, 944-950 (2002).
15. Knoechel B, Kahn E, Abbas AK. The link between lymphocyte deficiency and autoimmunity: roles of endogenous T and B lymphocytes in tolerance. J. Immunol. 175, 21-26 (2005).
16. Gunzer M, Hillmer A, Basoglu Y et al. A spectrum of biophysical interaction modes between T cells and different antigen-presenting cells during priming in 3-D collagen and in vivo. Blood 104, 2801-2809 (2004).
17. Gunzer M, Borgmann S, Grabbe S et al. Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential. Immunity 13, 323-332 (2000).
18. Okada T, Parker I, Krummel MF et al. Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells. PLoS Biol. 3, e150 (2005).
19. Reichhardt P, Dornbach B, Rong S et al. Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse. Blood 110 (5), 1519-1529 (2007).
20. Steinman RM, Nussenzweig MC. Tolerogenic dendritic cells. Ann. Rev. Immunol. 21, 685-711 (2001).
21. Black RA, Kozlosky CJ, Peschon JJ et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 385, 729-733 (1997).
22. Jung TM. Rapid modulation of homing receptors (gp90MEL-14) induced by activators of protein kinase C. Receptor shedding due to accelerated proteolytic cleavage at the cell surface. J. Immunol. 144, 3130-3136 (1990).
23. Brossard C, Schmitt A, Randriamampita C, Romao M, Raposo G, Trautmann A. Multifocal structure of the T cell - dendritic cell synapse. Eur. J. Immunol. 35, 1741-1753 (2005).
24. Coughlin CM, Vance BA, Grupp SA, Vonderheide RH. RNA-transfected CD40-activated B cells induce functional T cell responses against viral and tumor antigen targets: implications for pediatric immunotherapy. Blood 103(6), 2046-2054 (2003).
25. + regulatory T-cells including suppressors of alloreactivity. Immunol. Rev. 212, 314-329 (2005).
26. McCurry KR, Colvin BL, Zahorchak AF, Thomson AW. Regulatory dendritic cell therapy in organ transplantation. Transpl. Int. 19, 525-538 (2006).